ArticleVaccines2021

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study.

Léna Royston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.